| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 25.353 | 46.800 | 46.495 | 50.220 | 33.750 | 32.015 | 38.763 | 39.569 | 53.494 |
| Total Income - EUR | - | 25.353 | 46.800 | 46.495 | 50.220 | 35.751 | 32.015 | 38.763 | 39.569 | 53.494 |
| Total Expenses - EUR | - | 14.135 | 13.811 | 9.395 | 22.228 | 14.831 | 7.925 | 8.495 | 21.088 | 28.858 |
| Gross Profit/Loss - EUR | - | 11.218 | 32.989 | 37.100 | 27.992 | 20.920 | 24.090 | 30.268 | 18.481 | 24.636 |
| Net Profit/Loss - EUR | - | 10.460 | 31.585 | 35.705 | 26.485 | 20.129 | 23.149 | 29.319 | 18.105 | 23.111 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 2 |
Check the financial reports for the company - Ortoneurovit Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 717 | 506 | 301 | 138 | 0 | 0 | 0 | 0 | 4.219 |
| Current Assets | - | 12.345 | 38.293 | 37.954 | 30.538 | 22.667 | 23.746 | 30.139 | 18.927 | 26.039 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 0 | 0 | 0 | 311 | 228 | 0 | 18.250 | 246 | 22.114 |
| Cash | - | 12.345 | 38.293 | 37.954 | 30.227 | 22.438 | 23.746 | 11.889 | 18.680 | 3.926 |
| Shareholders Funds | - | 10.505 | 31.629 | 35.748 | 26.527 | 20.170 | 23.189 | 29.360 | 18.153 | 23.159 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 2.557 | 7.170 | 2.507 | 4.148 | 2.497 | 557 | 779 | 773 | 7.099 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Ortoneurovit Srl